Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nutriband Inc.

6.89
+1.2121.30%
Volume:577.27K
Turnover:4.07M
Market Cap:76.52M
PE:-6.96
High:8.11
Open:7.10
Low:6.45
Close:5.68
Loading ...

Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board

GlobeNewswire
·
11 Feb

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

GlobeNewswire
·
07 Feb

Nutriband Initiated at Outperform by Noble Capital Markets

Dow Jones
·
23 Jan

BUZZ-Nutriband rises as Noble Capital starts coverage with 'outperform'

Reuters
·
22 Jan

Nutriband Shares up 27% After Noble Capital Starts Coverage With Outperform Rating

THOMSON REUTERS
·
22 Jan

Nutriband Inc trading resumes

TIPRANKS
·
22 Jan

Nutriband Inc : Noble Capital Initiates Coverage With Outperform Rating; Price Target $13

THOMSON REUTERS
·
22 Jan

Most Shareholders Will Probably Find That The Compensation For Nutriband Inc.'s (NASDAQ:NTRB) CEO Is Reasonable

Simply Wall St.
·
18 Jan

Shareholders in Nutriband (NASDAQ:NTRB) are in the red if they invested five years ago

Simply Wall St.
·
08 Jan

Investors ignore increasing losses at Nutriband (NASDAQ:NTRB) as stock jumps 19% this past week

Simply Wall St.
·
02 Jan

Nutriband CEO still sees Aversa Fentanyl regulatory approval within 2025

TIPRANKS
·
31 Dec 2024

Nutriband Issues Letter to Shareholders

GlobeNewswire
·
31 Dec 2024

Nutriband Extends Chinese Patent to Macao for Aversa Technology

MT Newswires Live
·
27 Dec 2024

BRIEF-Nutriband Extends Chinese Patent To Macao For Its Aversa Abuse Deterrent Transdermal Technology

Reuters
·
27 Dec 2024

Nutriband extends Chinese patent to Macao for AVERSA technology

TIPRANKS
·
27 Dec 2024

Nutriband Extends Chinese Patent to Macao for Its Aversa™ Abuse Deterrent Transdermal Technology

THOMSON REUTERS
·
27 Dec 2024

Nutriband Inc: Targeting to File for FDA Approval for Aversa™ Fentanyl in First Half of 2025

THOMSON REUTERS
·
27 Dec 2024

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

GlobeNewswire
·
27 Dec 2024

Nutriband Q3 EPS $(0.12) Up From $(0.22) YoY, Sales $645.80K Up From $427.84K YoY

Benzinga
·
04 Dec 2024

Nutriband reports record revenue for Q3, progress to NDA for AVERSA

TIPRANKS
·
04 Dec 2024